The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | A | Alimentary tract and metabolism | |
| 2 | A10 | Drugs used in diabetes | |
| 3 | A10B | Blood glucose lowering drugs, excl. insulins | |
| 4 | A10BA | Biguanides | |
| 5 | A10BA02 | Metformin |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 2 g |
| Active Ingredient | Description | |
|---|---|---|
| Metformin |
Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| BROT Film-coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| DIABETMIN Prolonged release tablet | Marketing Authorisation Holder | MPI, EU: SmPC | |
| DIAFORMIN Film-coated tablet | Pharmaceutical Benefits Scheme (AU) | MPI, EU: SmPC | |
| GLUCOPHAGE Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| GLUCOPHAGE Tablet / Extended-release tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| GLUMETZA Film coated tablet, extended release | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| GLYFORMIN Film-coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| METFORAL Film-coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| METFORMIN Oral Solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
| SIOFOR Prolonged-release tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
